Loading clinical trials...
Loading clinical trials...
An Open-label Study to Evaluate the Single-dose Pharmacokinetics and Safety of Ceftobiprole in Neonate and Infant Subjects Aged up to 3 Months Undergoing Treatment With Systemic Antibiotics
Conditions
Interventions
Ceftobiprole medocaril
Locations
14
United States
Loma Linda University Medical Center
Loma Linda, California, United States
University of Southern California
Los Angeles, California, United States
University of California Los Angeles
Los Angeles, California, United States
Beacon Children's Hospital
South Bend, Indiana, United States
Norton Children's Hospital
Louisville, Kentucky, United States
Duke University Hospital
Durham, North Carolina, United States
Start Date
November 22, 2016
Primary Completion Date
February 25, 2020
Completion Date
February 25, 2020
Last Updated
June 5, 2023
NCT06704048
NCT04263792
NCT06135350
NCT06103500
NCT02979951
NCT06025682
Lead Sponsor
Basilea Pharmaceutica
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions